Chugai Pharmaceutical

Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases. It offers Actemra, an agent for rheumatoid arthritis and other autoimmune diseases, and Alecensa, an inhibitor for non-small cell lung cancer. The company also provides GC33, an antibody for hepatocellular carcinoma, and other medicines.